Stay Updated with the Latest PIMCO Funds Short Term Fund Institutional Shares PTSHX News in Real Time
Find PTSHX news now at Meyka AI. Stay informed with the latest PIMCO Funds Short Term Fund Institutional Shares stocks updates, including price news, market analysis, and expert insights.
Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update
Moderna jumped 177% to $174.38 after Phase 3 melanoma vaccine trial success with Merck. The mRNA therapy reduced recurrence risk and represents the first approved late-stage cancer vaccine.
Aldi Worker Ordered to Pay $1,230 After AI-Generated Unfair Dismissal Claim Fails
Sydney Aldi worker ordered to pay $1,230 in legal costs after Fair Work rejected his AI-generated unfair dismissal claim. He was dismissed three days short of the six-month eligibility threshold.
Pentagon Orders 30 U.S. Universities to Audit China Research Ties by August 31
Pentagon orders 30 U.S. universities to audit foreign research ties, mainly Chinese institutions, by August 31 or lose federal funding eligibility. Harvard, MIT, and Johns Hopkins among those affected.
NEAR Protocol USD Jumps 9.1% to $1.73 on Mid-Cap Rally
NEARUSD surged 9.1% to $1.7328 in 24 hours on August 20, 2026, outpacing mid-cap peers amid mixed technical signals.
Uniswap USD Jumps 10.6% to $3.64 on Heavy Volume Surge
UNIUSD rallied 10.6% to $3.64 in 24 hours as trading volume spiked 59% above the 30-day average on August 20, 2026.
Moderna Soars 177% After Melanoma Vaccine Clears Late-Stage Trial on August 19
Moderna jumps 177% and Merck gains 12% after their personalized mRNA cancer vaccine met key goals in a Phase 3 melanoma trial, the first positive late-stage result for an mRNA cancer therapy.
Zcash Rallies 11% to $564.94 After Institutional Mining Launch
Zcash jumped 11% to $564.94 on August 20 following Cypherpunk Technologies’ $33.33M mining operation launch, controlling 18% of network hashrate.
Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12%
Moderna jumped 177% and Merck rose 12% after announcing the first Phase 3 win for an mRNA cancer vaccine. The personalized treatment reduced melanoma recurrence risk significantly.
Wrapped Beacon ETH USD Surges 17.2% to $2,480 on Volume Spike
WBETHUSD jumped 17.2% to $2,480.21 in 24 hours on volume 163% above average, but technical indicators show overbought conditions.